302 results
Page 5 of 16
8-K
EX-99.1
ppzoox 9q27szgts4
22 Jan 19
Regulation FD Disclosure
8:00am
8-K
EX-99.1
xy76f
9 Aug 18
Caladrius Biosciences Reports 2018 Second Quarter and First Six Months Financial Results
4:04pm
424B5
56d9dbj oxnfv417kgk
2 Aug 18
Prospectus supplement for primary offering
5:21pm
424B2
14uy1obbv lubmqqwmk
2 Aug 18
Prospectus for primary offering
4:23pm
8-K
EX-99.1
3yv7rhixhcm
20 Jun 18
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina
1:28pm
8-K
qtoy8p1p lk9u5slmli
20 Jun 18
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina
1:28pm
8-K
EX-99.1
u44lwel6euo
10 May 18
Caladrius Biosciences Reports 2018 First Quarter Financial Results
4:07pm